Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robin Spiller

Showing results (41-50 of 85) with videos related to

Pageof 9
Sort By:
Lancet (London, England)|September 21, 2002
Irritable bowel syndrome: a little understood organic bowel disease?Nicholas J Talley, Robin Spiller
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 16, 2010
Do the symptom-based, Rome criteria of irritable bowel syndrome lead to better diagnosis and treatment outcomes?Robin Spiller, Michael Camilleri, George F Longstreth
Alimentary Pharmacology & Therapeutics|May 10, 2023
Editorial: ondansetron for patients with IBS-D and bowel-predominant symptoms-authors' replyDavid Gunn, Alexander Ford, Amanda Farrin, et al.
European Journal of Gastroenterology & Hepatology|August 12, 2005
Impact of bitter taste on gastric motilityDavid Wicks, Jeff Wright, Pip Rayment, et al.
Alimentary Pharmacology & Therapeutics|October 30, 2021
Small bowel water content assessed by MRI in health and disease: a collation of single-centre studiesNeele Dellschaft, Caroline Hoad, Luca Marciani, et al.
Expert Review of Respiratory Medicine|June 22, 2023
Thinking outside the box: a review of gastrointestinal symptoms and complications in cystic fibrosisAlexander Yule, Darren Sills, Sherie Smith, et al.
Gut|December 14, 2005
Hypervascular pancreatic massRobin Spiller, M Hartleb, A Nowak, et al.
Neurogastroenterology and Motility|November 2, 2025
Clinical Characteristics and Outcomes of Rome IV Diarrhea-Predominant Irritable Bowel Syndrome and Functional Diarrhea Prescribed With Ondansetron: A Real-World StudyCaterina Sbarigia, Christian Lambiase, Mohsin F Butt, et al.
Gut|April 15, 2008
Dysphagia and a skin rashG Watermeyer, D Epstein, S Hlatshwayo, et al.
The Journal of Physiology|July 26, 2008
Afferent hypersensitivity in a mouse model of post-inflammatory gut dysfunction: role of altered serotonin metabolismChristopher Keating, Michael Beyak, Stephen Foley, et al.
Pageof 9

Showing results (41-50 of 85) with videos related to

Sort By:
Pageof 9
Lancet (London, England)|September 21, 2002
Irritable bowel syndrome: a little understood organic bowel disease?Nicholas J Talley, Robin Spiller
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 16, 2010
Do the symptom-based, Rome criteria of irritable bowel syndrome lead to better diagnosis and treatment outcomes?Robin Spiller, Michael Camilleri, George F Longstreth
Alimentary Pharmacology & Therapeutics|May 10, 2023
Editorial: ondansetron for patients with IBS-D and bowel-predominant symptoms-authors' replyDavid Gunn, Alexander Ford, Amanda Farrin, et al.
European Journal of Gastroenterology & Hepatology|August 12, 2005
Impact of bitter taste on gastric motilityDavid Wicks, Jeff Wright, Pip Rayment, et al.
Alimentary Pharmacology & Therapeutics|October 30, 2021
Small bowel water content assessed by MRI in health and disease: a collation of single-centre studiesNeele Dellschaft, Caroline Hoad, Luca Marciani, et al.
Expert Review of Respiratory Medicine|June 22, 2023
Thinking outside the box: a review of gastrointestinal symptoms and complications in cystic fibrosisAlexander Yule, Darren Sills, Sherie Smith, et al.
Gut|December 14, 2005
Hypervascular pancreatic massRobin Spiller, M Hartleb, A Nowak, et al.
Neurogastroenterology and Motility|November 2, 2025
Clinical Characteristics and Outcomes of Rome IV Diarrhea-Predominant Irritable Bowel Syndrome and Functional Diarrhea Prescribed With Ondansetron: A Real-World StudyCaterina Sbarigia, Christian Lambiase, Mohsin F Butt, et al.
Gut|April 15, 2008
Dysphagia and a skin rashG Watermeyer, D Epstein, S Hlatshwayo, et al.
The Journal of Physiology|July 26, 2008
Afferent hypersensitivity in a mouse model of post-inflammatory gut dysfunction: role of altered serotonin metabolismChristopher Keating, Michael Beyak, Stephen Foley, et al.
Pageof 9